ALGN (Align Technology Inc) Market Value to Book Value Ratio

Align Technology Inc (ALGN) - corporate logo

Align Technology, Inc. (ALGN) possesses a sustainable liquidity surplus and a robust cash flow. Dominance in the 3D scanning and aligner segment guarantees high margins. Revenue is generated through B2B supplies of innovative systems for dental clinics. This P/B ratio chart helps assess the fairness of the assets' market price, with the 2.57 mark serving as the current indicator for this metric.

Market Capitalization to Net Assets: Align Corp (ALGN) for 07/04/2022 - 10/27/2026
Finished products of Invisalign

This multiple compares the current market value of Align Technology, Inc. (ALGN) to its net assets, demonstrating the degree of business overvaluation relative to its tangible base. By analyzing the history of the price-to-book ratio, an investor can see how the market values the company's intangible advantages—the 3D scanner ecosystem and physician loyalty—amid growing competition from D2C brands, which ultimately determines the asset's investment attractiveness.

Direct competitors

Market Value to Book Value Ratio Boston Scientific|EW (edwards.com) - Capitalization to Book Value Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|GMED: Market Capitalization to Book Value Ratio|Market-to-Book Ratio TransMedics Organ Care System TMDX|ATEC: Market Capitalization to Book Value Ratio|AORT - Market Cap to Net Assets Ratio|DJO Global - Market Capitalization to Book Value Ratio|Integra LifeSciences Inc. (IART) - Market Capitalization to Book Value|ESTA (Establishment Labs) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio BBNX|Market Value to Book Value Ratio IRADIMED (IRMD)|Market Value to Book Value Ratio Embecta Corp (EMBC)|Market Capitalization to Book Value Ratio TNDM|AXGN - Market Capitalization to Book Value|Market Cap to Net Assets Ratio SI-BONE, Inc.|OFIX - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio BVS|OrthoPediatrics (KIDS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Treace Medical (TMCI)|Capitalization to Book Value Ratio Strata Medical (SRTA)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO